Form 8-K - Current report:
SEC Accession No. 0001610618-21-000045
Filing Date
2021-05-13
Accepted
2021-05-13 16:15:11
Documents
16
Period of Report
2021-05-13
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K cdtx-20210513.htm   iXBRL 8-K 36634
2 EARNINGS RELEASE ex9912021-05x13.htm EX-99.1 49857
8 GRAPHIC cdtxlogoa181a.jpg GRAPHIC 63449
  Complete submission text file 0001610618-21-000045.txt   327301

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT cdtx-20210513.xsd EX-101.SCH 2418
4 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT cdtx-20210513_cal.xml EX-101.CAL 710
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT cdtx-20210513_def.xml EX-101.DEF 1647
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT cdtx-20210513_lab.xml EX-101.LAB 25298
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT cdtx-20210513_pre.xml EX-101.PRE 13190
9 EXTRACTED XBRL INSTANCE DOCUMENT cdtx-20210513_htm.xml XML 11213
Mailing Address 6310 NANCY RIDGE DRIVE SUITE 101 SAN DIEGO CA 92121
Business Address 6310 NANCY RIDGE DRIVE SUITE 101 SAN DIEGO CA 92121 858-752-6170
Cidara Therapeutics, Inc. (Filer) CIK: 0001610618 (see all company filings)

EIN.: 461537286 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36912 | Film No.: 21919805
SIC: 2836 Biological Products, (No Diagnostic Substances)